Baldwin Wealth Partners’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,000
Closed -$67K 705
2022
Q1
$67K Buy
7,000
+5,000
+250% +$47.9K 0.01% 329
2021
Q4
$38K Hold
2,000
﹤0.01% 383
2021
Q3
$67K Hold
2,000
0.01% 315
2021
Q2
$78K Hold
2,000
0.01% 302
2021
Q1
$96K Hold
2,000
0.01% 263
2020
Q4
$104K Sell
2,000
-15,850
-89% -$824K 0.01% 240
2020
Q3
$478K Hold
17,850
0.07% 106
2020
Q2
$348K Hold
17,850
0.05% 119
2020
Q1
$176K Sell
17,850
-10,000
-36% -$98.6K 0.03% 153
2019
Q4
$309K Sell
27,850
-2,000
-7% -$22.2K 0.04% 146
2019
Q3
$168K Hold
29,850
0.03% 185
2019
Q2
$258K Hold
29,850
0.04% 183
2019
Q1
$240K Buy
29,850
+12,000
+67% +$96.5K 0.04% 187
2018
Q4
$73K Hold
17,850
0.01% 252
2018
Q3
$100K Hold
17,850
0.01% 250
2018
Q2
$235K Hold
17,850
0.04% 182
2018
Q1
$253K Hold
17,850
0.04% 177
2017
Q4
$146K Hold
17,850
0.02% 215
2017
Q3
$212K Hold
17,850
0.03% 186
2017
Q2
$179K Hold
17,850
0.03% 195
2017
Q1
$208K Hold
17,850
0.03% 183
2016
Q4
$83K Buy
17,850
+2,000
+13% +$9.3K 0.02% 249
2016
Q3
$123K Hold
15,850
0.02% 207
2016
Q2
$96K Buy
15,850
+3,000
+23% +$18.2K 0.02% 211
2016
Q1
$109K Sell
12,850
-2,000
-13% -$17K 0.02% 230
2015
Q4
$177K Hold
14,850
0.03% 215
2015
Q3
$150K Buy
14,850
+900
+6% +$9.09K 0.03% 222
2015
Q2
$231K Sell
13,950
-1,000
-7% -$16.6K 0.03% 215
2015
Q1
$231K Buy
14,950
+1,000
+7% +$15.5K 0.03% 214
2014
Q4
$221K Buy
13,950
+2,750
+25% +$43.6K 0.03% 223
2014
Q3
$120K Buy
+11,200
New +$120K 0.02% 246